Detalles de la búsqueda
1.
Software with artificial intelligence-derived algorithms for analysing CT brain scans in people with a suspected acute stroke: a systematic review and cost-effectiveness analysis.
Health Technol Assess
; 28(11): 1-204, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38512017
2.
Oral Azacitidine for Maintenance Treatment of Acute Myeloid Leukaemia After Induction Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pharmacoeconomics
; 41(8): 857-867, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37129774
3.
Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pharmacoeconomics
; 41(7): 741-750, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36952138
4.
Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pharmacoeconomics
; 41(3): 239-251, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36725788
5.
Pralsetinib for RET Fusion-Positive Advanced Non-small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pharmacoeconomics
; 41(4): 353-361, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36757608
6.
Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pharmacoeconomics
; 40(5): 509-518, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34664200
7.
SpaceOAR Hydrogel Spacer for Reducing Radiation Toxicity During Radiotherapy for Prostate Cancer. A Systematic Review.
Urology
; 156: e74-e85, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34029607
8.
Filgotinib for Moderate to Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pharmacoeconomics
; 39(12): 1397-1410, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34448148
9.
Correction to: Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pharmacoeconomics
; 40(5): 575, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35364758
Resultados
1 -
9
de 9
1
Próxima >
>>